ESMO 2023: A new immunotherapy, volrustomig, for the first-line treatment of advanced kidney cancer
Blocking the action of two proteins in cancer cells (PD-1 [...]
ESMO 2023: A new first-line treatment, toripalimab, for advanced kidney cancer
Advanced/metastatic kidney cancer is often treated with a combination of [...]
ESMO 2023: Belzutifan for the treatment of advanced kidney cancer
Treatments for people with metastatic kidney cancer have changed over [...]
Injectable form of nivolumab
An injectable form of nivolumab has been successful in clinical [...]
SMC approves belzutifan for VHL kidney cancer in Scotland
We are delighted to announce that the Scottish Medicines Consortium [...]
Kidney function 5 years after SABR for primary kidney cancer
Stereotactic ablative body radiotherapy (SABR) uses high doses of radiation [...]
SABR for older patients with inoperable kidney cancer
The incidence of renal cell carcinoma (RCC) has increased worldwide [...]
Tips for staying strong with advanced kidney cancer
This article, published in Health Central gives some good tips to [...]
Leicester NHS Trust receives funding for robotic surgery theatre
Robotic surgery will be used in more procedures in Leicester [...]
Belzutifan significantly delays progression of advanced kidney cancer after other treatments have failed
Kidney cancers often have mutations in a gene called the von Hippel-Lindau [...]
